Status:
ENROLLING_BY_INVITATION
Clinical Efficacy and Mechanism of rTMS Based on dlPFC in the Intervention of Generalized Anxiety Disorder With Insomnia
Lead Sponsor:
Yanghua Tian
Conditions:
Generalized Anxiety Disorder (GAD)
Insomnia
Eligibility:
All Genders
15-65 years
Phase:
NA
Brief Summary
To investigate the intervention effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on insomnia symptoms of generalized anxiety disorder patients.
Detailed Description
Stimulation was performed using a figure 8-shaped focal coil attached to a MagPro 100 magnetic stimulator (MagVenture, Copenhagen, Denmark). All patients received 1 Hz (10 s trains, 1 s inter-train in...
Eligibility Criteria
Inclusion
- age between 15 and 65 years;
- clinically diagnosed with anxiety according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V);
- no previous application of any insomnia pharmacological therapy for at least one week before baseline visit.
Exclusion
- current or history of serious brain and body diseases;
- current or history of schizophrenia, behavioral problems, post-traumatic stress disorder, mania, obsessive-compulsive disorder, and social phobia;
- substance abuse or other comorbid psychological diseases.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06931236
Start Date
August 1 2024
End Date
December 31 2025
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anhui Medical University
Hefei, Anhui, China